GV20 Therapeutics

[GV20 Therapeutics @GV20_tx]

We are excited to welcome our advisers Alessandra Cesano, Julie Cherrington, and Mike Varney! Read more about these renowned #oncology leaders in our press release: https://t.co/mXNDp1wxSd

[GV20 Therapeutics @GV20_tx]

Meet Ying Gong, Chief Business Officer, and Steven Landau, Chief Medical Officer! They’re both experienced #oncology leaders, and we’re grateful to have their expertise as we work to identify novel #cancer drug targets and develop antibody medicines. #AI #FunctionalGenomics

[GV20 Therapeutics @GV20_tx]

Meet Dr. Shirley Liu! A co-founder of the company, she’s now taking on the role of CEO to lead us through our next stage of growth and transition into a clinical-stage company.

#Leadership #AI #FunctionalGenomics #ComputationalBiology

[GV20 Therapeutics @GV20_tx]

We’re pleased to announce the appointment of Shirley Liu, Ying Gong and Steven Landau to our executive team! Together, they bring extensive experience in oncology research, #DrugDevelopment and corporate strategy.

Read more ➡️ https://t.co/LkgmBeuPxB

#FunctionalGenomics #AI